Influenza Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Indication, By Route Of Administration, By Age Group, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 3 Business Days
Influenza Vaccine Market Growth & Trends
The global influenza vaccine market size is expected to reach USD 12.37 billion by 2030 and is set to expand at 6.83% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The increase in immunization programs, rising awareness regarding flu and influenza, and surge in R&D activities pertaining to flu vaccines are anticipated to propel market growth. In addition, the inclusion of the influenza vaccine in various national immunization programs and increasing awareness programs for immunizations across the globe is anticipated to boost the market growth.
The ongoing influenza vaccination national schemes globally are anticipated to propel the market. For instance, programs such as Universal Influenza Immunization Program and NIP Vaccination Programs among others are some of the key immunization programs. These offer flu vaccines free of cost to all the target population. The key objective of such programs is to eliminate the risk of flu-like disorders.
Trivalent and Quadrivalent vaccines are commercially available influenza vaccines. Among these, the quadrivalent vaccines are the most preferred type owing to their high efficacy and their ability to combat two influenza-B viruses and two influenza-A viruses. Leading companies are undertaking efforts to conduct research studies for quadrivalent product development. For instance, in November 2022, Pfizer Inc. and BioNTech SE announced the advancement of an mRNA-based combination vaccine candidate for COVID-19 and influenza to mitigate two life-threatening respiratory conditions.
Moreover, due to the emergence of new strains, scientists are devising a vaccination strategy that could prevent the flu virus with multiple strains and achieve long-lasting immunity in an individual. For instance, in March 2022, scientists from Monash University, Melbourne, and the National University of Singapore published research in the ‘Proceedings of the National Academy of Sciences’. This research featured a platform to efficiently offer vaccine candidate M2e to the immune cells to attain long-lasting immunity against different virus strains.
Furthermore, various initiatives undertaken by leading market participants are likely to provide exponential growth opportunities for the market. For instance, in February 2020, Abbott announced the launch of inactivated quadrivalent vaccine for protection against four virus strains in India. In addition, in January 2021, ModernaTX, Inc. announced the company’s plans to use mRNA technology to manufacture and develop Nipah, HIV, and flu virus vaccines.
Influenza Vaccine Market Report Highlights
Influenza Vaccine Market Growth & Trends
The global influenza vaccine market size is expected to reach USD 12.37 billion by 2030 and is set to expand at 6.83% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The increase in immunization programs, rising awareness regarding flu and influenza, and surge in R&D activities pertaining to flu vaccines are anticipated to propel market growth. In addition, the inclusion of the influenza vaccine in various national immunization programs and increasing awareness programs for immunizations across the globe is anticipated to boost the market growth.
The ongoing influenza vaccination national schemes globally are anticipated to propel the market. For instance, programs such as Universal Influenza Immunization Program and NIP Vaccination Programs among others are some of the key immunization programs. These offer flu vaccines free of cost to all the target population. The key objective of such programs is to eliminate the risk of flu-like disorders.
Trivalent and Quadrivalent vaccines are commercially available influenza vaccines. Among these, the quadrivalent vaccines are the most preferred type owing to their high efficacy and their ability to combat two influenza-B viruses and two influenza-A viruses. Leading companies are undertaking efforts to conduct research studies for quadrivalent product development. For instance, in November 2022, Pfizer Inc. and BioNTech SE announced the advancement of an mRNA-based combination vaccine candidate for COVID-19 and influenza to mitigate two life-threatening respiratory conditions.
Moreover, due to the emergence of new strains, scientists are devising a vaccination strategy that could prevent the flu virus with multiple strains and achieve long-lasting immunity in an individual. For instance, in March 2022, scientists from Monash University, Melbourne, and the National University of Singapore published research in the ‘Proceedings of the National Academy of Sciences’. This research featured a platform to efficiently offer vaccine candidate M2e to the immune cells to attain long-lasting immunity against different virus strains.
Furthermore, various initiatives undertaken by leading market participants are likely to provide exponential growth opportunities for the market. For instance, in February 2020, Abbott announced the launch of inactivated quadrivalent vaccine for protection against four virus strains in India. In addition, in January 2021, ModernaTX, Inc. announced the company’s plans to use mRNA technology to manufacture and develop Nipah, HIV, and flu virus vaccines.
Influenza Vaccine Market Report Highlights
- The inactivated segment held the largest share in 2022 owing to the high prevalence of flu along with the surge in demand for effective vaccines
- The quadrivalent segment registered the fastest growth rate in 2022 because of its high efficacy against viral infections, cost-effectiveness, and easy availability at different healthcare facilities
- The adult segment accounted for the largest market in 2022 due to governments’ efforts towards immunization programs and high vaccine dose procurement by UNICEF, GAVI, and PAHO for the adult population
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Competitive Insights
CHAPTER 3 INFLUENZA VACCINE MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increase in prevalence of influenza
3.2.1.2 Active government support to promote vaccinations
3.2.2 Market restraint analysis
3.2.2.1 Longer timeline for vaccine production
3.3 Penetration & Growth Prospect Mapping
3.4 Influenza Vaccine: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
CHAPTER 4 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY VACCINE TYPE, 2018 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Vaccine Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Influenza Vaccine Market, by Vaccine Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Inactivated
4.5.1.1 Inactivated market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Live Attenuated
4.5.2.1 Live Attenuated market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY INDICATION 2018 - 2030 (USD MILLION)
5.1 Definition and Scope
5.2 Indication Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Influenza Vaccine Market, by Indication, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Quadrivalent
5.5.1.1 Quadrivalent market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Trivalent
5.5.2.1 Trivalent market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
6.1 Definition and Scope
6.2 Route of Administration Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Influenza Vaccine Market, by Route of Administration, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Injection
6.5.1.1 Injection market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Nasal Spray
6.5.2.1 Nasal Spray market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY AGE GROUP, 2018 - 2030 (USD MILLION)
7.1 Definition and Scope
7.2 Age Group Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Influenza Vaccine Market, by Age Group, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Pediatric
7.5.1.1 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Adult
7.5.2.1 Adult market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
8.1 Definition and Scope
8.2 Distribution Channel Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Global Influenza Vaccine Market, by Distribution Channel, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Hospitals & Pharmacy
8.5.1.1 Hospitals & Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
8.5.2 Government & Institutional Supply
8.5.2.1 Government & Institutional Supply market estimates and forecast, 2018 - 2030 (USD Million)
8.5.3 Other
8.5.3.1 Other market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 SWOT Analysis
9.5.1 North America
9.5.2 Europe
9.5.3 Asia Pacific
9.5.4 Latin America
9.5.5 Middle East and Africa
9.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
9.6.1 North America
9.6.1.1 North America influenza vaccine market, 2018 - 2030 (USD Million)
9.6.1.2 U.S.
9.6.1.2.1 Key Country Dynamics
9.6.1.2.2 Competitive Scenario
9.6.1.2.3 Regulatory Framework
9.6.1.2.4 Reimbursement Scenario
9.6.1.2.5 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
9.6.1.3 Canada
9.6.1.3.1 Key Country Dynamics
9.6.1.3.2 Competitive Scenario
9.6.1.3.3 Regulatory Framework
9.6.1.3.4 Reimbursement Scenario
9.6.1.3.5 Canada market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2 Europe
9.6.2.1 Europe influenza vaccine market, 2018 - 2030 (USD Million)
9.6.2.2 U.K.
9.6.2.2.1 Key Country Dynamics
9.6.2.2.2 Competitive Scenario
9.6.2.2.3 Regulatory Framework
9.6.2.2.4 Reimbursement Scenario
9.6.2.2.5 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.3 Germany
9.6.2.3.1 Key Country Dynamics
9.6.2.3.2 Competitive Scenario
9.6.2.3.3 Regulatory Framework
9.6.2.3.4 Reimbursement Scenario
9.6.2.3.5 Germany market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.4 Spain
9.6.2.4.1 Key Country Dynamics
9.6.2.4.2 Competitive Scenario
9.6.2.4.3 Regulatory Framework
9.6.2.4.4 Reimbursement Scenario
9.6.2.4.5 Spain market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.5 France
9.6.2.5.1 Key Country Dynamics
9.6.2.5.2 Competitive Scenario
9.6.2.5.3 Regulatory Framework
9.6.2.5.4 Reimbursement Scenario
9.6.2.5.5 France market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.6 Italy
9.6.2.6.1 Key Country Dynamics
9.6.2.6.2 Competitive Scenario
9.6.2.6.3 Regulatory Framework
9.6.2.6.4 Reimbursement Scenario
9.6.2.6.5 Italy market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.7 Denmark
9.6.2.7.1 Key Country Dynamics
9.6.2.7.2 Competitive Scenario
9.6.2.7.3 Regulatory Framework
9.6.2.7.4 Reimbursement Scenario
9.6.2.7.5 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.8 Sweden
9.6.2.8.1 Key Country Dynamics
9.6.2.8.2 Competitive Scenario
9.6.2.8.3 Regulatory Framework
9.6.2.8.4 Reimbursement Scenario
9.6.2.8.5 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.9 Norway
9.6.2.9.1 Key Country Dynamics
9.6.2.9.2 Competitive Scenario
9.6.2.9.3 Regulatory Framework
9.6.2.9.4 Reimbursement Scenario
9.6.2.9.5 Norway market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3 Asia Pacific
9.6.3.1 Asia Pacific influenza vaccine market, 2018 - 2030 (USD Million)
9.6.3.2 Japan
9.6.3.2.1 Key Country Dynamics
9.6.3.2.2 Competitive Scenario
9.6.3.2.3 Regulatory Framework
9.6.3.2.4 Reimbursement Scenario
9.6.3.2.5 Japan market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.3 China
9.6.3.3.1 Key Country Dynamics
9.6.3.3.2 Competitive Scenario
9.6.3.3.3 Regulatory Framework
9.6.3.3.4 Reimbursement Scenario
9.6.3.3.5 China market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.4 India
9.6.3.4.1 Key Country Dynamics
9.6.3.4.2 Competitive Scenario
9.6.3.4.3 Regulatory Framework
9.6.3.4.4 Reimbursement Scenario
9.6.3.4.5 India market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.5 South Korea
9.6.3.5.1 Key Country Dynamics
9.6.3.5.2 Competitive Scenario
9.6.3.5.3 Regulatory Framework
9.6.3.5.4 Reimbursement Scenario
9.6.3.25.5 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.6 Australia
9.6.3.6.1 Key Country Dynamics
9.6.3.6.2 Competitive Scenario
9.6.3.6.3 Regulatory Framework
9.6.3.6.4 Reimbursement Scenario
9.6.3.6.5 Australia market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.7 Thailand
9.6.3.7.1 Key Country Dynamics
9.6.3.7.2 Competitive Scenario
9.6.3.7.3 Regulatory Framework
9.6.3.7.4 Reimbursement Scenario
9.6.3.7.5 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4 Latin America
9.6.4.1 Latin America influenza vaccine market, 2018 - 2030 (USD Million)
9.6.4.2 Brazil
9.6.4.2.1 Key Country Dynamics
9.6.4.2.2 Competitive Scenario
9.6.4.2.3 Regulatory Framework
9.6.4.2.4 Reimbursement Scenario
9.6.4.2.5 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4.3 Mexico
9.6.4.3.1 Key Country Dynamics
9.6.4.3.2 Competitive Scenario
9.6.4.3.3 Regulatory Framework
9.6.4.3.4 Reimbursement Scenario
9.6.4.3.5 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4.4 Argentina
9.6.4.4.1 Key Country Dynamics
9.6.4.4.2 Competitive Scenario
9.6.4.4.3 Regulatory Framework
9.6.4.4.4 Reimbursement Scenario
9.6.4.4.5 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5 MEA
9.6.5.1 MEA influenza vaccine market, 2018 - 2030 (USD Million)
9.6.5.2 South Africa
9.6.5.2.1 Key Country Dynamics
9.6.5.2.2 Competitive Scenario
9.6.5.2.3 Regulatory Framework
9.6.5.2.4 Reimbursement Scenario
9.6.5.2.5 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5.3 Saudi Arabia
9.6.5.3.1 Key Country Dynamics
9.6.5.3.2 Competitive Scenario
9.6.5.3.3 Regulatory Framework
9.6.5.3.4 Reimbursement Scenario
9.6.5.3.5 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5.4 UAE
9.6.5.4.1 Key Country Dynamics
9.6.5.4.2 Competitive Scenario
9.6.5.4.3 Regulatory Framework
9.6.5.4.4 Reimbursement Scenario
9.6.5.4.5 UAE market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5.5 Kuwait
9.6.5.5.1 Key Country Dynamics
9.6.5.5.2 Competitive Scenario
9.6.5.5.3 Regulatory Framework
9.6.5.5.4 Reimbursement Scenario
9.6.5.5.5 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 10 INFLUENZA VACCINE MARKET - COMPETITIVE ANALYSIS
10.1 Recent Developments & Impact Analysis, by Key Market Participants
10.1.1 Ansoff matrix
10.1.2 Heat map analysis
10.1.3 Major Deals and Strategic Alliances Analysis
10.1.3.1 Joint Ventures
10.1.3.2 Licensing Agreements
10.1.3.3 Product Launches
10.1.3.4 Conferences and Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.3 Vendor Landscape
10.3.1 List of key distributors and channel partners
10.3.2 Key customers
10.4 Public Companies
10.4.1 Competitive Dashboard Analysis
10.4.1.1 Market Differentiators
10.5 Private Companies
10.5.1 List of key emerging companies
10.6 Company Profiles
10.6.1 GSK plc
10.6.1.1 Company overview
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic Initiatives
10.6.2 AstraZeneca
10.6.2.1 Company overview
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic Initiatives
10.6.3 SINOVAC
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic Initiatives
10.6.4 Vaxess Technologies Inc
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic Initiatives
10.6.5 Pfizer Inc
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic Initiatives
10.6.6 CSL Limited
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic Initiatives
10.6.7 EMERGENT
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Merck & Co., Inc.
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Viatris Inc.
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives
10.6.10 OSIVAX, EMERGEX VACCINES
10.6.10.1 Company overview
10.6.10.2 Financial performance
10.6.10.3 Product benchmarking
10.6.10.4 Strategic initiatives
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Competitive Insights
CHAPTER 3 INFLUENZA VACCINE MARKET VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increase in prevalence of influenza
3.2.1.2 Active government support to promote vaccinations
3.2.2 Market restraint analysis
3.2.2.1 Longer timeline for vaccine production
3.3 Penetration & Growth Prospect Mapping
3.4 Influenza Vaccine: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
CHAPTER 4 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY VACCINE TYPE, 2018 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Vaccine Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Influenza Vaccine Market, by Vaccine Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Inactivated
4.5.1.1 Inactivated market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Live Attenuated
4.5.2.1 Live Attenuated market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY INDICATION 2018 - 2030 (USD MILLION)
5.1 Definition and Scope
5.2 Indication Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Influenza Vaccine Market, by Indication, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Quadrivalent
5.5.1.1 Quadrivalent market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Trivalent
5.5.2.1 Trivalent market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
6.1 Definition and Scope
6.2 Route of Administration Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Influenza Vaccine Market, by Route of Administration, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Injection
6.5.1.1 Injection market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Nasal Spray
6.5.2.1 Nasal Spray market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY AGE GROUP, 2018 - 2030 (USD MILLION)
7.1 Definition and Scope
7.2 Age Group Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Influenza Vaccine Market, by Age Group, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Pediatric
7.5.1.1 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Adult
7.5.2.1 Adult market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
8.1 Definition and Scope
8.2 Distribution Channel Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Global Influenza Vaccine Market, by Distribution Channel, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Hospitals & Pharmacy
8.5.1.1 Hospitals & Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
8.5.2 Government & Institutional Supply
8.5.2.1 Government & Institutional Supply market estimates and forecast, 2018 - 2030 (USD Million)
8.5.3 Other
8.5.3.1 Other market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 INFLUENZA VACCINE MARKET SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 SWOT Analysis
9.5.1 North America
9.5.2 Europe
9.5.3 Asia Pacific
9.5.4 Latin America
9.5.5 Middle East and Africa
9.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
9.6.1 North America
9.6.1.1 North America influenza vaccine market, 2018 - 2030 (USD Million)
9.6.1.2 U.S.
9.6.1.2.1 Key Country Dynamics
9.6.1.2.2 Competitive Scenario
9.6.1.2.3 Regulatory Framework
9.6.1.2.4 Reimbursement Scenario
9.6.1.2.5 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
9.6.1.3 Canada
9.6.1.3.1 Key Country Dynamics
9.6.1.3.2 Competitive Scenario
9.6.1.3.3 Regulatory Framework
9.6.1.3.4 Reimbursement Scenario
9.6.1.3.5 Canada market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2 Europe
9.6.2.1 Europe influenza vaccine market, 2018 - 2030 (USD Million)
9.6.2.2 U.K.
9.6.2.2.1 Key Country Dynamics
9.6.2.2.2 Competitive Scenario
9.6.2.2.3 Regulatory Framework
9.6.2.2.4 Reimbursement Scenario
9.6.2.2.5 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.3 Germany
9.6.2.3.1 Key Country Dynamics
9.6.2.3.2 Competitive Scenario
9.6.2.3.3 Regulatory Framework
9.6.2.3.4 Reimbursement Scenario
9.6.2.3.5 Germany market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.4 Spain
9.6.2.4.1 Key Country Dynamics
9.6.2.4.2 Competitive Scenario
9.6.2.4.3 Regulatory Framework
9.6.2.4.4 Reimbursement Scenario
9.6.2.4.5 Spain market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.5 France
9.6.2.5.1 Key Country Dynamics
9.6.2.5.2 Competitive Scenario
9.6.2.5.3 Regulatory Framework
9.6.2.5.4 Reimbursement Scenario
9.6.2.5.5 France market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.6 Italy
9.6.2.6.1 Key Country Dynamics
9.6.2.6.2 Competitive Scenario
9.6.2.6.3 Regulatory Framework
9.6.2.6.4 Reimbursement Scenario
9.6.2.6.5 Italy market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.7 Denmark
9.6.2.7.1 Key Country Dynamics
9.6.2.7.2 Competitive Scenario
9.6.2.7.3 Regulatory Framework
9.6.2.7.4 Reimbursement Scenario
9.6.2.7.5 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.8 Sweden
9.6.2.8.1 Key Country Dynamics
9.6.2.8.2 Competitive Scenario
9.6.2.8.3 Regulatory Framework
9.6.2.8.4 Reimbursement Scenario
9.6.2.8.5 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2.9 Norway
9.6.2.9.1 Key Country Dynamics
9.6.2.9.2 Competitive Scenario
9.6.2.9.3 Regulatory Framework
9.6.2.9.4 Reimbursement Scenario
9.6.2.9.5 Norway market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3 Asia Pacific
9.6.3.1 Asia Pacific influenza vaccine market, 2018 - 2030 (USD Million)
9.6.3.2 Japan
9.6.3.2.1 Key Country Dynamics
9.6.3.2.2 Competitive Scenario
9.6.3.2.3 Regulatory Framework
9.6.3.2.4 Reimbursement Scenario
9.6.3.2.5 Japan market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.3 China
9.6.3.3.1 Key Country Dynamics
9.6.3.3.2 Competitive Scenario
9.6.3.3.3 Regulatory Framework
9.6.3.3.4 Reimbursement Scenario
9.6.3.3.5 China market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.4 India
9.6.3.4.1 Key Country Dynamics
9.6.3.4.2 Competitive Scenario
9.6.3.4.3 Regulatory Framework
9.6.3.4.4 Reimbursement Scenario
9.6.3.4.5 India market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.5 South Korea
9.6.3.5.1 Key Country Dynamics
9.6.3.5.2 Competitive Scenario
9.6.3.5.3 Regulatory Framework
9.6.3.5.4 Reimbursement Scenario
9.6.3.25.5 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.6 Australia
9.6.3.6.1 Key Country Dynamics
9.6.3.6.2 Competitive Scenario
9.6.3.6.3 Regulatory Framework
9.6.3.6.4 Reimbursement Scenario
9.6.3.6.5 Australia market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3.7 Thailand
9.6.3.7.1 Key Country Dynamics
9.6.3.7.2 Competitive Scenario
9.6.3.7.3 Regulatory Framework
9.6.3.7.4 Reimbursement Scenario
9.6.3.7.5 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4 Latin America
9.6.4.1 Latin America influenza vaccine market, 2018 - 2030 (USD Million)
9.6.4.2 Brazil
9.6.4.2.1 Key Country Dynamics
9.6.4.2.2 Competitive Scenario
9.6.4.2.3 Regulatory Framework
9.6.4.2.4 Reimbursement Scenario
9.6.4.2.5 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4.3 Mexico
9.6.4.3.1 Key Country Dynamics
9.6.4.3.2 Competitive Scenario
9.6.4.3.3 Regulatory Framework
9.6.4.3.4 Reimbursement Scenario
9.6.4.3.5 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4.4 Argentina
9.6.4.4.1 Key Country Dynamics
9.6.4.4.2 Competitive Scenario
9.6.4.4.3 Regulatory Framework
9.6.4.4.4 Reimbursement Scenario
9.6.4.4.5 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5 MEA
9.6.5.1 MEA influenza vaccine market, 2018 - 2030 (USD Million)
9.6.5.2 South Africa
9.6.5.2.1 Key Country Dynamics
9.6.5.2.2 Competitive Scenario
9.6.5.2.3 Regulatory Framework
9.6.5.2.4 Reimbursement Scenario
9.6.5.2.5 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5.3 Saudi Arabia
9.6.5.3.1 Key Country Dynamics
9.6.5.3.2 Competitive Scenario
9.6.5.3.3 Regulatory Framework
9.6.5.3.4 Reimbursement Scenario
9.6.5.3.5 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5.4 UAE
9.6.5.4.1 Key Country Dynamics
9.6.5.4.2 Competitive Scenario
9.6.5.4.3 Regulatory Framework
9.6.5.4.4 Reimbursement Scenario
9.6.5.4.5 UAE market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5.5 Kuwait
9.6.5.5.1 Key Country Dynamics
9.6.5.5.2 Competitive Scenario
9.6.5.5.3 Regulatory Framework
9.6.5.5.4 Reimbursement Scenario
9.6.5.5.5 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 10 INFLUENZA VACCINE MARKET - COMPETITIVE ANALYSIS
10.1 Recent Developments & Impact Analysis, by Key Market Participants
10.1.1 Ansoff matrix
10.1.2 Heat map analysis
10.1.3 Major Deals and Strategic Alliances Analysis
10.1.3.1 Joint Ventures
10.1.3.2 Licensing Agreements
10.1.3.3 Product Launches
10.1.3.4 Conferences and Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.3 Vendor Landscape
10.3.1 List of key distributors and channel partners
10.3.2 Key customers
10.4 Public Companies
10.4.1 Competitive Dashboard Analysis
10.4.1.1 Market Differentiators
10.5 Private Companies
10.5.1 List of key emerging companies
10.6 Company Profiles
10.6.1 GSK plc
10.6.1.1 Company overview
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic Initiatives
10.6.2 AstraZeneca
10.6.2.1 Company overview
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic Initiatives
10.6.3 SINOVAC
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic Initiatives
10.6.4 Vaxess Technologies Inc
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic Initiatives
10.6.5 Pfizer Inc
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic Initiatives
10.6.6 CSL Limited
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic Initiatives
10.6.7 EMERGENT
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Merck & Co., Inc.
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Viatris Inc.
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives
10.6.10 OSIVAX, EMERGEX VACCINES
10.6.10.1 Company overview
10.6.10.2 Financial performance
10.6.10.3 Product benchmarking
10.6.10.4 Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Influenza Vaccine Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 6 Global Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 7 Global Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 8 Global Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 9 Global Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 North America Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 12 North America Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 13 North America Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 North America Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 15 North America Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 U.S. Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 17 U.S. Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 18 U.S. Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 U.S. Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 20 U.S. Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 21 Canada Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 22 Canada Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 23 Canada Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 24 Canada Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 25 Canada Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Europe Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 27 Europe Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 28 Europe Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 29 Europe Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 Europe Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 31 Europe Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Germany Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 33 Germany Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 34 Germany Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 Germany Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 36 Germany Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 U.K. Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 38 U.K. Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 39 U.K. Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 U.K. Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 41 U.K. Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 France Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 43 France Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 44 France Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 France Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 46 France Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Italy Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 48 Italy Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 49 Italy Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Italy Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 51 Italy Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Spain Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 53 Spain Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 54 Spain Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Spain Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 56 Spain Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 Denmark Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 58 Denmark Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 59 Denmark Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 60 Denmark Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 61 Denmark Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Norway Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 63 Norway Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 64 Norway Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 65 Norway Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 66 Norway Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Sweden Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 68 Sweden Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 69 Sweden Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 Sweden Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 71 Sweden Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Asia Pacific Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 73 Asia Pacific Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 74 Asia Pacific Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 75 Asia Pacific Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 Asia Pacific Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 77 Asia Pacific Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 78 Japan Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 79 Japan Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 80 Japan Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 81 Japan Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 82 Japan Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 China Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 84 China Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 85 China Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 China Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 87 China Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 India Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 89 India Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 90 India Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 India Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 92 India Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 South Korea Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 94 South Korea Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 95 South Korea Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 South Korea Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 97 South Korea Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 98 Australia Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 99 Australia Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 100 Australia Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 101 Australia Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 102 Australia Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 103 Thailand Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 104 Thailand Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 105 Thailand Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 106 Thailand Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 107 Thailand Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 108 Latin America Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 109 Latin America Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 110 Latin America Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 111 Latin America Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 112 Latin America Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 113 Latin America Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 Brazil Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 115 Brazil Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 116 Brazil Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 Brazil Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 118 Brazil Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 119 Mexico Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 120 Mexico Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 121 Mexico Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 122 Mexico Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 123 Mexico Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 124 Argentina Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 125 Argentina Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 126 Argentina Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 127 Argentina Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 128 Argentina Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 129 Middle East and Africa Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 130 Middle East and Africa Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 131 Middle East and Africa Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 132 Middle East and Africa Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 133 Middle East and Africa Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 134 Middle East and Africa Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 135 South Africa Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 136 South Africa Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 137 South Africa Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 138 South Africa Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 139 South Africa Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 143 Saudi Arabia Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 144 Saudi Arabia Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 145 UAE Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 146 UAE Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 147 UAE Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 148 UAE Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 149 UAE Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 150 Kuwait Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 151 Kuwait Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 152 Kuwait Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 153 Kuwait Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 154 Kuwait Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Influenza Vaccine Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 6 Global Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 7 Global Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 8 Global Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 9 Global Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 North America Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 12 North America Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 13 North America Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 North America Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 15 North America Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 U.S. Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 17 U.S. Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 18 U.S. Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 U.S. Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 20 U.S. Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 21 Canada Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 22 Canada Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 23 Canada Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 24 Canada Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 25 Canada Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Europe Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 27 Europe Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 28 Europe Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 29 Europe Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 Europe Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 31 Europe Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Germany Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 33 Germany Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 34 Germany Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 Germany Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 36 Germany Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 U.K. Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 38 U.K. Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 39 U.K. Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 U.K. Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 41 U.K. Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 France Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 43 France Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 44 France Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 France Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 46 France Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Italy Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 48 Italy Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 49 Italy Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Italy Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 51 Italy Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Spain Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 53 Spain Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 54 Spain Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Spain Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 56 Spain Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 Denmark Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 58 Denmark Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 59 Denmark Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 60 Denmark Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 61 Denmark Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Norway Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 63 Norway Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 64 Norway Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 65 Norway Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 66 Norway Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Sweden Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 68 Sweden Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 69 Sweden Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 Sweden Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 71 Sweden Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Asia Pacific Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 73 Asia Pacific Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 74 Asia Pacific Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 75 Asia Pacific Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 Asia Pacific Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 77 Asia Pacific Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 78 Japan Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 79 Japan Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 80 Japan Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 81 Japan Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 82 Japan Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 China Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 84 China Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 85 China Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 China Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 87 China Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 India Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 89 India Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 90 India Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 India Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 92 India Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 South Korea Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 94 South Korea Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 95 South Korea Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 South Korea Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 97 South Korea Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 98 Australia Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 99 Australia Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 100 Australia Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 101 Australia Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 102 Australia Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 103 Thailand Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 104 Thailand Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 105 Thailand Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 106 Thailand Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 107 Thailand Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 108 Latin America Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 109 Latin America Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 110 Latin America Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 111 Latin America Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 112 Latin America Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 113 Latin America Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 Brazil Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 115 Brazil Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 116 Brazil Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 Brazil Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 118 Brazil Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 119 Mexico Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 120 Mexico Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 121 Mexico Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 122 Mexico Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 123 Mexico Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 124 Argentina Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 125 Argentina Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 126 Argentina Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 127 Argentina Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 128 Argentina Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 129 Middle East and Africa Influenza Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 130 Middle East and Africa Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 131 Middle East and Africa Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 132 Middle East and Africa Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 133 Middle East and Africa Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 134 Middle East and Africa Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 135 South Africa Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 136 South Africa Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 137 South Africa Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 138 South Africa Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 139 South Africa Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 143 Saudi Arabia Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 144 Saudi Arabia Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 145 UAE Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 146 UAE Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 147 UAE Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 148 UAE Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 149 UAE Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 150 Kuwait Influenza Vaccine Market, By Vaccine Type, 2018 - 2030 (USD Million)
Table 151 Kuwait Influenza Vaccine Market, By Indication, 2018 - 2030 (USD Million)
Table 152 Kuwait Influenza Vaccine Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 153 Kuwait Influenza Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 154 Kuwait Influenza Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Influenza vaccine market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value - chain - based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Influenza vaccine market: Vaccine type movement analysis
Fig. 17 Influenza vaccine market: Vaccine type segment dashboard
Fig. 18 Influenza vaccine market Vaccine type outlook: Key takeaways
Fig. 19 Inactivated market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Live attenuated market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Influenza vaccine market: Indication movement analysis
Fig. 22 Influenza vaccine market: Indication segment dashboard
Fig. 23 Influenza vaccine market Indication outlook: Key takeaways
Fig. 24 Quadrivalent market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Trivalent market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Influenza vaccine market: Route of administration movement analysis
Fig. 27 Influenza vaccine market: Route of administration segment dashboard
Fig. 28 Influenza vaccine market Route of administration outlook: Key takeaways
Fig. 29 Injection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Nasal Spray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Influenza vaccine market: Age group movement analysis
Fig. 32 Influenza vaccine market: Age group segment dashboard
Fig. 33 Influenza vaccine market Age group outlook: Key takeaways
Fig. 34 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Adult market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Influenza vaccine market: Distribution channel movement analysis
Fig. 37 Influenza vaccine market: Distribution channel segment dashboard
Fig. 38 Influenza vaccine market Distribution channel outlook: Key takeaways
Fig. 39 Hospitals & Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Government & Institutional supply market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2022 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 58 U.K.
Fig. 59 U.K. influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 70 Sweden
Fig. 71 Sweden influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 72 Norway
Fig. 73 Norway influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 86 Thailand
Fig. 87 Thailand influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 104 Kuwait
Fig. 105 Kuwait influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 106 Ansoff Matrix
Fig. 107 Heat map analysis
Fig. 108 Market differentiators
Fig. 1 Influenza vaccine market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value - chain - based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Influenza vaccine market: Vaccine type movement analysis
Fig. 17 Influenza vaccine market: Vaccine type segment dashboard
Fig. 18 Influenza vaccine market Vaccine type outlook: Key takeaways
Fig. 19 Inactivated market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Live attenuated market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Influenza vaccine market: Indication movement analysis
Fig. 22 Influenza vaccine market: Indication segment dashboard
Fig. 23 Influenza vaccine market Indication outlook: Key takeaways
Fig. 24 Quadrivalent market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Trivalent market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Influenza vaccine market: Route of administration movement analysis
Fig. 27 Influenza vaccine market: Route of administration segment dashboard
Fig. 28 Influenza vaccine market Route of administration outlook: Key takeaways
Fig. 29 Injection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Nasal Spray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Influenza vaccine market: Age group movement analysis
Fig. 32 Influenza vaccine market: Age group segment dashboard
Fig. 33 Influenza vaccine market Age group outlook: Key takeaways
Fig. 34 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Adult market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Influenza vaccine market: Distribution channel movement analysis
Fig. 37 Influenza vaccine market: Distribution channel segment dashboard
Fig. 38 Influenza vaccine market Distribution channel outlook: Key takeaways
Fig. 39 Hospitals & Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Government & Institutional supply market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2022 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional marketplace: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 58 U.K.
Fig. 59 U.K. influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 70 Sweden
Fig. 71 Sweden influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 72 Norway
Fig. 73 Norway influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 86 Thailand
Fig. 87 Thailand influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 104 Kuwait
Fig. 105 Kuwait influenza vaccine market, 2018 - 2030 (USD Million)
Fig. 106 Ansoff Matrix
Fig. 107 Heat map analysis
Fig. 108 Market differentiators
